Award for Product Safety, Innovation & Transparency goes to biosurfactant RHEANCE® One. ... MORE
Despite a difficult first quarter, Evonik confirms its earnings forecast for 2023. ... MORE
Company agrees to $75,000 civil penalty for violating permitted emission limits for hazardous air pollutants in Reserve, La. New control technologies and a supplemental environmental program will reduce emissions. ... MORE
Curiteva’s world’s first 3D printed spinal implants for commercial use are based on Evonik’s VESTAKEEP® i4 3DF biomaterial filament. ... MORE
Evonik’s Lipid Innovation Center is being built on the grounds of the company’s site in Tippecanoe and will position Evonik for future growth in novel mRNA-based therapies beyond COVID-19 vaccines. ... MORE
After a challenging year 2022, Evonik is cautiously optimistic for 2023. ... MORE
